The French health authorities stopped a clinical trial not authorized carried out in some 350 patients, especially patients of alzheimer's disease and párkinson , by a controversial doctor who claims to be inspired by God and is known for his opposition to vaccines.
the National Agency for The Surveillance of the Drug (MSNA, by its French acronym) warned of possible " health risk "among the patients that underwent this treatment to the base of skin patches in which the doctors included in a molecule" whose quality, effect and tolerance are not known ".
The clinical trial was led by doctor Jean-Bernard Fourtillan , a controversial physician who, in your web page, ensures that their knowledge was "revealed" as "a man of faith who loves and listens to God."
The MSNA urged him to stop the clinical trial and to alert all the patients, at the time that brought the case to the attention of the justice by these "illegal practices", said in a statement. It also recommended that patients go to their family physician and undergo a complete checkup to possible side effects .
Fourtillan applied to the candidates, sick of alzheimer's disease, párkinson and other neurological pathologies, skin patches at the base of a derivative of melatonin .
The responsible proceeded to draw blood to the patients in an abbey near Poitiers, south of Paris, from which they were sent to a laboratory, which was subject to an inspection of the MSNA, which discovered the existence of the clinical trial.
According to the tv BFM, some of the patients were inmates of that abbey, while others went there last night before they draw the blood the following morning.
The minister of Health, Agnès Buzyn, calling it "absolute scandal" the "essay" savage " developed "outside of any ethical framework" and on an "inadmissible".
In remarks to the BFM indicated that the perpetrators of this practice hid the patients to the doctors and he denounced those who exploit the fragility of severely ill patients to offer them "miracle treatments".
Buzyn gave no further details about the "ongoing investigation" and said the priority of his department is now dealing with the patients affectedUpdated Date: 20 September 2019, 19:01